You are here

Greg Conko on FDA Approval for Avastin

CEI Senior Fellow Greg Conko discusses the FDA's pending decision on whether or not to withdraw its approval of Avastin as a treatment for breast cancer. Greg argues that because it is effective for a small proportion of breast cancer patients, they should be able to decide for themselves if they want to use it.